Prevalence of Atherosclerotic Cardiovascular Disease, Heart Failure, and Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus: A Primary Care Research Network-based Study | Zendy

Geert Goderis | Zendy; Bert Vaes | Zendy; Pavlos Mamouris | Zendy; Eline Van Craeyveld | Zendy; Chantal Mathieu | Zendy

Open Access

Prevalence of Atherosclerotic Cardiovascular Disease, Heart Failure, and Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus: A Primary Care Research Network-based Study

Author(s) -

Geert Goderis,

Bert Vaes,

Pavlos Mamouris,

Eline Van Craeyveld,

Chantal Mathieu

Publication year - 2021

Publication title -

experimental and clinical endocrinology and diabetes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.632

H-Index - 76

eISSN - 1439-3646

pISSN - 0947-7349

DOI - 10.1055/a-1508-3912

Subject(s) - medicine , kidney disease , heart failure , diabetes mellitus , type 2 diabetes , metformin , blood pressure , type 2 diabetes mellitus , comorbidity , cardiology , stroke (engine) , endocrinology , mechanical engineering , engineering

This study aims to assess the prevalence of atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), chronic kidney disease (CKD), and their combined presence in type 2 diabetes (T2D) patients in primary care for whom the 2019 ADA/EASD consensus update "Management of Hyperglycemia in Type 2 Diabetes" recommends GLP-1 receptor agonists (GLP-1RA) or sodium-glucose cotransporter-2 inhibitors (SGLT-I) as first-line medications after metformin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research